---
document_datetime: 2023-09-21 19:47:41
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/bevespi-aerosphere-epar-all-authorised-presentations_en.pdf
document_name: bevespi-aerosphere-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6526293
conversion_datetime: 2025-12-19 03:25:06.644474
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

| EU/1/18/1339/001   | Bevespi Aerosphere   | 7.2 µg / 5.0µg   | Pressurised inhalation, suspension            | Inhalation use                              | Inhaler (alu (with FEP/PES 1 inhaler (120 actuations)   |
|--------------------|----------------------|------------------|-----------------------------------------------|---------------------------------------------|---------------------------------------------------------|
| EU/1/18/1339/002   | Bevespi Aerosphere   | 7.2 µg / 5.0µg   | Pressurised inhalation, suspension Inhalation | use inhaler (alu (with FEP/PES coating)/PP) | 3 (3x1) inhalers (360(3x120) actuations) (multipack)    |